Table 2. Pre-Treatment Characteristics of Patients With Helicobacter pylori Eradication (N = 19).

Age (years)	68.1 ± 5.3
Gender (male/female)	8/11
AST (IU/L)	54.6 ± 30.8
ALT (IU/L)	50.8 ± 42.6
γ-GTP (IU/L)	41.4 ± 30.3
ALP (IU/L)	280.9 ± 103.4
Total bilirubin (mg/dL)	1.0 ± 0.3
Albumin (g/dL)	3.8 ± 0.5
Hemoglobin (g/dL)	12.1 ± 1.7
Platelets (× 103/μL)	91.6 ± 30.2
Prothrombin time (%)	80.8 ± 12.8
HCV genotype (group 1/2)	14/5
HCV RNA (Log copies/mL)	5.7 ± 0.8
Chronic hepatitis/Child-Pugh A cirrhosis/Child-Pugh B cirrhosis/Child-Pugh C cirrhosis	4/13/2/0